| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |